Mao Li Li
Mao Li Li — Chief Physician — Melanoma & Sarcoma — Peking University Cancer Hospital
Specialties
Melanoma, soft tissue sarcoma, kidney cancer, renal pelvis cancer, ureter cancer, bladder cancer, testicular cancer, urothelial carcinoma, squamous cell carcinoma immunotherapy BRAF mutation
Education
Received a PhD in Oncology from Peking University in 2011
Professional Experience
Chief Physician of the Department of Medical Oncology for Melanoma and Sarcoma, specializing in the drug treatment of malignant melanoma, sarcoma, renal cancer, and urothelial carcinoma for many years, with a primary focus on clinical new drug research and translational research of melanoma. As a key participant in clinical studies, this work has led to the approval and marketing of multiple new drugs, and several innovative treatment strategies have been incorporated into domestic and international diagnosis and treatment guidelines.
Professional Roles
Currently serving as the Secretary of the Melanoma Quality Control Expert Committee of the National Cancer Quality Control Center, a standing member of the Melanoma Expert Committee of the Chinese Society of Clinical Oncology, and a member of the Sarcoma Expert Committee of the Chinese Society of Clinical Oncology. As a contributing author, participated in compiling the National Health Commission's "Guidelines for the Diagnosis and Treatment of Melanoma," the Chinese Society of Clinical Oncology's "Guidelines for the Diagnosis and Treatment of Melanoma," and the Chinese Anti-Cancer Association's "Guidelines for Integrated Diagnosis and Treatment of Cancer (Melanoma)."